Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

2.3K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K
Antifungal Agents01:15

Antifungal Agents

119
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
119

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design, synthesis, and structure-activity relationship study of novel GLP-1/GIP/GCG triple receptor agonists.

European journal of medicinal chemistry·2025
Same author

Discovery of <b>TQ-3959</b> as a Potent and Orally Bioavailable BTK PROTAC Degrader Incorporating a Novel Benzisoxazole-Based CRBN Ligand for the Treatment of B-Cell Malignancies.

Journal of medicinal chemistry·2025
Same author

Design of a novel long-acting insulin analogs by acetylation modification and compared with insulin Icodec.

Scientific reports·2025
Same author

Histopathology image classification based on semantic correlation clustering domain adaptation.

Artificial intelligence in medicine·2025
Same author

Exploring the potential association between stimulant or atomoxetine use and suicidal or self-injurious behaviors in children with attention deficit hyperactivity disorder: real-world insights from the FAERS database.

European child & adolescent psychiatry·2025
Same author

Physiologically-based pharmacokinetic modeling to predict the exposure and to assess pharmacodynamics of daptomycin in infants within 1 year old.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2025

Related Experiment Video

Updated: May 6, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

18.8K

DMR040, a potential antifungal compound.

Jinhua Zhang1,2, Hongjiang Xu3, Yuanzhen Dong4

  • 1School of Biological Engineering Henan University of Technology, Zhengzhou, Henan, China. jinhuazhang1991@outlook.com.

The Journal of Antibiotics
|January 6, 2025
PubMed
Summary
This summary is machine-generated.

A novel amphotericin B derivative, DMR040, demonstrates potent antifungal activity against Candida albicans with reduced toxicity. Its unique self-association in solution may explain its enhanced efficacy in vivo.

More Related Videos

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
06:47

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products

Published on: December 5, 2020

6.2K
Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
09:44

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis

Published on: June 13, 2021

2.7K

Related Experiment Videos

Last Updated: May 6, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

18.8K
Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
06:47

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products

Published on: December 5, 2020

6.2K
Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
09:44

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis

Published on: June 13, 2021

2.7K

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Mycology

Background:

  • Amphotericin B (AmB) is a crucial antifungal agent, but its clinical use is limited by significant toxicity.
  • Modifications of AmB, such as DMR022 and DMR031, aim to improve its therapeutic index.
  • DMR040 is a newly designed AmB derivative incorporating 8-amino-3,6-dioxaoctanoic acid (AEEA) linkers.

Purpose of the Study:

  • To synthesize and evaluate the antifungal activity and hemolytic toxicity of the novel amphotericin B derivative, DMR040.
  • To compare the in vitro and in vivo efficacy of DMR040 with amphotericin B and related derivatives.
  • To investigate the potential mechanisms underlying DMR040's improved biological performance.

Main Methods:

  • Antifungal activity was assessed using the broth dilution method against Candida albicans strains.
  • Hemolytic toxicity was evaluated using sterile defibrinated sheep blood.
  • In vivo efficacy was determined through studies in mice, with pharmacokinetic parameters like volume of distribution (Vd) and serum half-life measured.

Main Results:

  • DMR040 exhibited a minimal inhibitory concentration (MIC) of 2 μg/mL against Candida albicans, showing a 2-fold improvement over amphotericin B.
  • No hemolysis was observed with DMR040 even at high concentrations (128 μg/mL), indicating significantly reduced toxicity.
  • In vivo studies revealed DMR040 to be 7-14 times more effective than amphotericin B in mice, potentially due to its self-association properties in PBS.

Conclusions:

  • DMR040 represents a promising new derivative of amphotericin B with enhanced antifungal potency and markedly reduced hemolytic toxicity.
  • The observed self-association of DMR040 in solution may contribute to its superior in vivo efficacy compared to amphotericin B and other derivatives.
  • Despite its improved efficacy, DMR040 displayed a smaller volume of distribution and shorter serum half-life in mice than amphotericin B deoxycholate.